These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32730923)

  • 21. The A242T mutation in the low-density lipoprotein receptor-related protein 5 gene in one Chinese family with osteosclerosis.
    Wang C; Zhang BH; Zhang H; He JW; Hu YQ; Li M; Yue H; Hu WW; Gu JM; Liu YJ; Fu WZ; Zhang ZL
    Intern Med; 2013; 52(2):187-92. PubMed ID: 23318847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated circulating Sclerostin concentrations in individuals with high bone mass, with and without LRP5 mutations.
    Gregson CL; Poole KE; McCloskey EV; Duncan EL; Rittweger J; Fraser WD; Smith GD; Tobias JH
    J Clin Endocrinol Metab; 2014 Aug; 99(8):2897-907. PubMed ID: 24606091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss-of-Function Mutations in the WNT Co-receptor LRP6 Cause Autosomal-Dominant Oligodontia.
    Massink MP; Créton MA; Spanevello F; Fennis WM; Cune MS; Savelberg SM; Nijman IJ; Maurice MM; van den Boogaard MJ; van Haaften G
    Am J Hum Genet; 2015 Oct; 97(4):621-6. PubMed ID: 26387593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel variant in LRP6 associated with unusual and severe clinical presentation: Case report.
    Previdi A; Dubourg C; Cormier Daire V; Fradin M; Collet C
    Clin Genet; 2024 Jun; 105(6):666-670. PubMed ID: 38385987
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Yu M; Fan Z; Wong SW; Sun K; Zhang L; Liu H; Feng H; Liu Y; Han D
    J Dent Res; 2021 Apr; 100(4):415-422. PubMed ID: 33164649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lrp5 and Lrp6 play compensatory roles in mouse intestinal development.
    Zhong Z; Baker JJ; Zylstra-Diegel CR; Williams BO
    J Cell Biochem; 2012 Jan; 113(1):31-8. PubMed ID: 21866564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesd is a universal inhibitor of Wnt coreceptors LRP5 and LRP6 and blocks Wnt/beta-catenin signaling in cancer cells.
    Lu W; Liu CC; Thottassery JV; Bu G; Li Y
    Biochemistry; 2010 Jun; 49(22):4635-43. PubMed ID: 20446724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Idiopathic Juvenile Osteoporosis: Clinical Experience from a Single Centre and Screening of LRP5 and LRP6 Genes.
    Franceschi R; Vincenzi M; Camilot M; Antoniazzi F; Freemont AJ; Adams JE; Laine C; Makitie O; Mughal MZ
    Calcif Tissue Int; 2015 Jun; 96(6):575-9. PubMed ID: 25783012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An LRP6 mutation (Arg360His) associated with low bone mineral density but not cardiovascular events in a Caucasian family.
    Puente N; Vega AI; Hernandez JL; Fernandez-Luna JL; Riancho JA
    Osteoporos Int; 2022 Nov; 33(11):2445-2448. PubMed ID: 35840698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Idiopathic Acquired Osteosclerosis in a Middle-Aged Woman With Systemic Lupus Erythematosus.
    Guañabens N; Mumm S; Gifre L; Ruiz-Gaspà S; Demertzis JL; Stolina M; Novack DV; Whyte MP
    J Bone Miner Res; 2016 Sep; 31(9):1774-82. PubMed ID: 27005479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LRP6 mediates Wnt/β-catenin signaling and regulates adipogenic differentiation in human mesenchymal stem cells.
    Peröbner I; Karow M; Jochum M; Neth P
    Int J Biochem Cell Biol; 2012 Nov; 44(11):1970-82. PubMed ID: 22871567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lrp6 hypomorphic mutation affects bone mass through bone resorption in mice and impairs interaction with Mesd.
    Kubota T; Michigami T; Sakaguchi N; Kokubu C; Suzuki A; Namba N; Sakai N; Nakajima S; Imai K; Ozono K
    J Bone Miner Res; 2008 Oct; 23(10):1661-71. PubMed ID: 18505367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis.
    van Meurs JB; Trikalinos TA; Ralston SH; Balcells S; Brandi ML; Brixen K; Kiel DP; Langdahl BL; Lips P; Ljunggren O; Lorenc R; Obermayer-Pietsch B; Ohlsson C; Pettersson U; Reid DM; Rousseau F; Scollen S; Van Hul W; Agueda L; Akesson K; Benevolenskaya LI; Ferrari SL; Hallmans G; Hofman A; Husted LB; Kruk M; Kaptoge S; Karasik D; Karlsson MK; Lorentzon M; Masi L; McGuigan FE; Mellström D; Mosekilde L; Nogues X; Pols HA; Reeve J; Renner W; Rivadeneira F; van Schoor NM; Weber K; Ioannidis JP; Uitterlinden AG;
    JAMA; 2008 Mar; 299(11):1277-90. PubMed ID: 18349089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levels of serotonin, sclerostin, bone turnover markers as well as bone density and microarchitecture in patients with high-bone-mass phenotype due to a mutation in Lrp5.
    Frost M; Andersen T; Gossiel F; Hansen S; Bollerslev J; van Hul W; Eastell R; Kassem M; Brixen K
    J Bone Miner Res; 2011 Aug; 26(8):1721-8. PubMed ID: 21351148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of the Bone Phenotype and microRNA Profile in Adults With Low-Density Lipoprotein Receptor-Related Protein 5-High Bone Mass (LRP5-HBM) Disease.
    Lauterlein JL; Gossiel F; Weigl M; Eastell R; Hackl M; Hermann P; Bollerslev J; Frost M
    JBMR Plus; 2021 Sep; 5(9):e10534. PubMed ID: 34532618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-bone-mass-producing mutations in the Wnt signaling pathway result in distinct skeletal phenotypes.
    Niziolek PJ; Farmer TL; Cui Y; Turner CH; Warman ML; Robling AG
    Bone; 2011 Nov; 49(5):1010-9. PubMed ID: 21855668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissecting molecular differences between Wnt coreceptors LRP5 and LRP6.
    MacDonald BT; Semenov MV; Huang H; He X
    PLoS One; 2011; 6(8):e23537. PubMed ID: 21887268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sclerosteosis: Report of type 1 or 2 in three Indian Tamil families and literature review.
    Whyte MP; Deepak Amalnath S; McAlister WH; Pedapati R; Muthupillai V; Duan S; Huskey M; Bijanki VN; Mumm S
    Bone; 2018 Nov; 116():321-332. PubMed ID: 30077757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The extracellular domain of Lrp5/6 inhibits noncanonical Wnt signaling in vivo.
    Bryja V; Andersson ER; Schambony A; Esner M; Bryjová L; Biris KK; Hall AC; Kraft B; Cajanek L; Yamaguchi TP; Buckingham M; Arenas E
    Mol Biol Cell; 2009 Feb; 20(3):924-36. PubMed ID: 19056682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic analysis of high bone mass cases from the BARCOS cohort of Spanish postmenopausal women.
    Sarrión P; Mellibovsky L; Urreizti R; Civit S; Cols N; García-Giralt N; Yoskovitz G; Aranguren A; Malouf J; Di Gregorio S; Río LD; Güerri R; Nogués X; Díez-Pérez A; Grinberg D; Balcells S
    PLoS One; 2014; 9(4):e94607. PubMed ID: 24736728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.